Drug Discovery - Medicine.net

Medication still better than procedure for some irregular heartbeat conditions

Updated on: December 16,2025

0

Medication still better than procedure for some irregular heartbeat conditions

Updated on:December 16,2025

0

LDL cholesterol improved among veterans in program with health coaches, other resources

Updated on: December 16,2025

0

LDL cholesterol improved among veterans in program with health coaches, other resources

Updated on:December 16,2025

0

Combo pill boosts heart function, symptoms, life quality

Updated on: December 16,2025

0

Combo pill boosts heart function, symptoms, life quality

Updated on:December 16,2025

0

Investigational daily pill lowered bad cholesterol as much as injectables

Updated on: December 16,2025

0

Investigational daily pill lowered bad cholesterol as much as injectables

Updated on:December 16,2025

0

One month of clot prevention after a stent was as effective as year-long course for AFib

Updated on: December 16,2025

0

One month of clot prevention after a stent was as effective as year-long course for AFib

Updated on:December 16,2025

0

To get representative health data, researchers hand out fitbits

Updated on: November 03,2025

0

To get representative health data, researchers hand out fitbits

Updated on:November 03,2025

0

Researchers discover a type of fibroblast that may contribute to the formation and recurrence of overgrown scars

Updated on: November 03,2025

0

Researchers discover a type of fibroblast that may contribute to the formation and recurrence of overgrown scars

Updated on:November 03,2025

0

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for

Updated on: December 02,2025

0

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for

Updated on:December 02,2025

0

Cancer researchers highlight role of nanomedicine in next-generation immunotherapies

Medication still better than procedure for some irregular heartbeat conditions

Medication still better than procedure for some irregular heartbeat conditions

LDL cholesterol improved among veterans in program with health coaches, other resources

LDL cholesterol improved among veterans in program with health coaches, other resources

Combo pill boosts heart function, symptoms, life quality

Combo pill boosts heart function, symptoms, life quality

Investigational daily pill lowered bad cholesterol as much as injectables

Investigational daily pill lowered bad cholesterol as much as injectables

One month of clot prevention after a stent was as effective as year-long course for AFib

One month of clot prevention after a stent was as effective as year-long course for AFib

To get representative health data, researchers hand out fitbits

To get representative health data, researchers hand out fitbits

Researchers discover a type of fibroblast that may contribute to the formation and recurrence of overgrown scars

Researchers discover a type of fibroblast that may contribute to the formation and recurrence of overgrown scars

Weekly Update of Drug News-2/12/2025

Weekly Update of Drug News-2/12/2025

Cancer researchers highlight role of nanomedicine in next-generation immunotherapies

Cancer researchers highlight role of nanomedicine in next-generation immunotherapies

Research highlights solutions to critical gaps in dementia and childhood cancer care

Research highlights solutions to critical gaps in dementia and childhood cancer care